New African, March 1st, 2000
Forty Kenyans are to undergo a new Aids vaccine trial to help verify its efficacy. The vaccine has been developed by a group of British, Canadian and Kenyan scientists in Nairobi, led by Professor Andrew McMichael from Oxford University in England.
Dr Joshua Kimani, one of the Kenyan scientists on the UN-sponsored project, says the vaccine is DNA-based and consists of DNA strands from the HIV virus attached to another virus called MVA, which was used in the development of the small pox vaccine.
"Ideally, during the first phase, we'll be interested in health-conscious people, who are at a low...
HighBeam Research, Free Preview: 'HIV vaccine trial'... Full Membership required for unlimited access. Free 7-day trial.
Subscribers: HighBeam content is only available to HighBeam subscribers. Click the link above for more information.
